Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Thailand New upcoming elections could change cannabis regulations…
  • North Dakota - United States Amended bill would regulate revocation of medical cannabis patients’ ID cards& ...
  • Oklahoma - United States Senate bill to keep grow facilities from places of worship heads to House…
  • Montana - United States Bill to make delta-8 a controlled substance goes to governor…
  • Brazil Superior court to decide on hemp cultivation for medical purposes…
  • Canada Cannabis fees rise in line with inflation…
  • Kentucky - United States Bill to ban delta-8 sales to under-21s land on governor’s desk…
  • Oklahoma - United States House approves extension to Medical Marijuana Authority’s powers…
  • Spain Podemos and allies call for hemp regulation…
  • Belgium Positive notifications list updated…
  • Bulgaria Industrial cannabis THC limit could be increased…
  • Germany Public hearing held over decriminalising cannabis…
View all
Daily news alerts

Trials on medicines containing cannabidiol for children with epilepsy…

Written by CannIntelligence || 3rd March 2022 || Daily news alerts | Regulation and legislation | Europe United Kingdom

UK: During a debate about treatments for children with epilepsy, the minister for care and mental health, Gillian Keegan, said that the National Institute for Health Research (NIHR) and the NHS will support a programme of two randomised control trials on epilepsy, which will compare medicines containing cannabidiol, and CBD plus tetrahydrocannabinol and a placebo. “This is a pioneering area » Continue Reading. ...

Restricted content. Do you want to read more?

Read our latest free content
Yellow card offence – but comments are a long way from being a dismissal of CBD
Mayhem in Mexico as agency grants firm hemp licence then vows to take it back
Relaxation beats intoxication – IHDC sales aren’t just about getting high
Spannabis: a celebration of the cannabis sector despite lingering uncertainties
Trulieve ends 2022 with over $1bn in revenue, 25 new dispensaries in the US
22nd Century’s cannabinoid division helps the company to double revenue

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.